- COVID-19
- CMS Waivers and Services Impacted by End of the Public Health Emergency
- Claim Billing Guidance
- COVID-19 Part A Frequently Asked Questions
- COVID-19 Vaccine and Monoclonal Antibody
- Medicare Coverage of Over-the-Counter COVID-19 Tests
- Medicare Part A and B Billing for the COVID-19 Vaccine and Monoclonal Antibody
- OIG Guidance for COVID-19 Vaccination
Claim Billing Guidance
With the end of the PHE, as of 5/11/2023, this information no longer applies. We will keep the information available for PHE-related services that occurred prior to the expiration date that have not yet been billed.
- Clarification on the Proper Use of the CS Modifier
- Modifiers Used During the COVID-19 Public Health Emergency
- Modifier 95 as it Relates to Medicare Part B and COVID-19 Billing
- Modifier CR as it Relates to Medicare Part B and COVID-19 Billing
- Modifier CS and COVID-19 Billing
- MLN Matters® MM11791 Revised: Therapy Codes Update
- MLN Connects® Special Edition for Tuesday, May 19, 2020: COVID-19: Payment for Lab Tests, Safely Reopening Nursing Homes, Lab & Ambulance Claims
- Medicare Coverage and Payment Related to COVID-19
- MLN Matters® SE20011 Revised: Medicare Fee-for-Service (FFS) Response to the Public Health Emergency on the Coronavirus
- Medicare Administrative Contractor (MAC) COVID-19 Test Pricing
- Frequently Asked Questions (FAQs), CLIA Guidance During the COVID-19 Emergency
Reviewed 10/14/2024